Skip to main content
芭薇股份 logo

芭薇股份 — Investor Relations & Filings

Ticker · 920123 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2025-08-26 Governance Information
Country CN China
Listing Beijing Stock Exchange 920123

About 芭薇股份

https://www.gzbawei.com/

Guangdong Bawei Biotechnology Corp., Ltd. is a comprehensive beauty and personal care solution provider specializing in research, development, production, and testing. The company offers integrated OEM, ODM, and OBM services, covering a wide range of product categories including skincare, hair care, body care, and makeup. Bawei is recognized for its commitment to scientific innovation, operating advanced R&D laboratories and an independent third-party testing center that ensures product safety and efficacy. By leveraging automated production lines and a rigorous quality management system, the company serves a diverse portfolio of domestic and international brands. Its core focus remains on delivering high-quality, customized formulations and manufacturing excellence to meet evolving consumer demands in the global beauty market.

Recent filings

Filing Released Lang Actions
内幕信息知情人登记及保密制度
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '内幕信息知情人登记及保密制度' (Insider Information Insider Registration and Confidentiality System) issued by Guangdong Bawei Biotechnology Co., Ltd. It outlines the company's procedures and responsibilities regarding insider information management, confidentiality, insider registration, and legal compliance. The document references regulatory bodies such as the China Securities Regulatory Commission and Beijing Stock Exchange, and includes detailed procedural rules, responsibilities of board members and insiders, and legal consequences for violations. It is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and compliance practices related to insider information management. Therefore, the most appropriate classification is Governance Information (CGR). The document length (8036 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2025-08-26 Chinese
为全资子公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company providing a guarantee for its wholly-owned subsidiary's loan. It details the guarantee amount, the decision-making process, risk assessment, and the impact on the company. It includes board meeting resolutions and opinions from the sponsoring institution. The document does not contain financial statements or detailed financial reports but is a regulatory announcement about a financing-related guarantee. It is not a full financial report, audit report, or earnings release. The content fits best under Capital/Financing Update (CAP) as it relates to financing activities and guarantees provided by the company.
2025-08-26 Chinese
关于取消监事会、变更注册资本、经营范围并修订《公司章程》公告
Governance Information Classification · 95% confidence The document is a detailed announcement from Guangdong Bawei Biotechnology Co., Ltd. regarding amendments to the company's articles of association, changes in registered capital, business scope, and corporate governance rules. It includes extensive legal and regulatory references, detailed provisions about shareholder rights and obligations, board and management responsibilities, and compliance with securities laws. The content is focused on governance structure, shareholder relations, and corporate bylaws rather than financial results or audit opinions. There is no indication that this is an annual report, audit report, earnings release, or any other financial statement. Instead, it is a governance-related disclosure about changes to the company's articles of association and corporate governance practices. Therefore, the most appropriate classification is Governance Information (CGR). The document length and detail confirm it is the actual governance document, not just an announcement of publication or a brief summary.
2025-08-26 Chinese
关于部分募投项目投资总额、内部投资结构调整及延期的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Guangdong Bawei Biotechnology Co., Ltd. regarding adjustments to the total investment amount, internal investment structure, and delays of certain fundraising projects. It includes detailed information about the use of funds raised through a public stock issuance, adjustments to project budgets, and postponement of project completion dates. The document references approvals by the board of directors, supervisory board, and independent directors, and mentions that the matter will be submitted to the shareholders' meeting for approval. The content focuses on fundraising project investment adjustments and related disclosures rather than financial results, audit opinions, or management discussions. It is not a full annual or interim report, nor a call transcript or earnings release. It is a regulatory announcement about capital use and project investment changes, fitting the category of Capital/Financing Update (CAP). The document length is about 4737 characters, which is substantive and contains detailed financial and project investment data, not merely an announcement of a report publication or a certification letter. Therefore, the best classification is CAP with high confidence.
2025-08-26 Chinese
第四届董事会第七次会议决议公告
Board/Management Information Classification · 100% confidence The document is a detailed announcement of resolutions passed at the seventh meeting of the fourth board of directors of Guangdong Bawei Biotechnology Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to other related announcements and reports. The content focuses on board decisions, governance matters, and approvals of various company reports and policies. There is no actual financial data or full report content included; rather, it is a formal record of board meeting decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management.
2025-08-26 Chinese
第四届监事会第四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangdong Bawei Biotechnology Co., Ltd. It details the convening and attendance of the Supervisory Board meeting, the agenda items discussed, and the voting results on various proposals including approval of the 2025 semi-annual report and related fundraising usage reports. The document references other detailed reports published on the Beijing Stock Exchange information disclosure platform but itself is a formal announcement of the Supervisory Board meeting resolutions. It does not contain the full semi-annual report or detailed financial data but rather the meeting decisions and approvals. This fits the category of a Regulatory Filing (RNS) as it is a formal regulatory announcement of board resolutions and approvals without substantive financial statements or detailed report content.
2025-08-26 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.